Please login to the form below

Not currently logged in
Email:
Password:

Annexa

This page shows the latest Annexa news and features for those working in and with pharma, biotech and healthcare.

Novel anticoagulant antidotes prove their worth

Novel anticoagulant antidotes prove their worth

Portola Pharmaceuticals and Bristol-Myers Squibb (BMS) has reported phase III data on its Factor Xa inhibitor antidote Annexa (andexanet alfa), showing it can effectively reverse the anticoagulant effects of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics